HCAR2 and myeloid sarcoma: Treatment with DMF ameliorates the clinical course of experimental autoimmune encephalomyelitis (EAE), the model for MS, in wild-type, but not HCAR2-deficient, mice by reducing the infiltration of neutrophils involved in disease progression (7).